blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Phenotypic data: Why genetic data needs context in research

Genetic data is at the heart of precision medicine. Understanding the influence of genetics on health has helped us to identify risk factors for disease, predic...
Continue reading

COVID-19 and genomic sequencing: Tracking variants and lessons for future pandemics

As COVID-19 continues to affect us all, it has become evident that our fight against the virus is not just about developing vaccines and therapeutics. Equally c...
Continue reading

The long haul: How long COVID continues to challenge healthcare

Long COVID, affecting nearly 28% of COVID-19 survivors, is a multifaceted condition that extends well beyond its initial impact. Typical include fatigue, concen...
Continue reading

The genetic evidence advantage in drug development

In the ever-evolving world of healthcare and pharmaceuticals, researchers are constantly seeking ways to make drug development more efficient and effective. San...
Continue reading

Genetic data sources for drug discovery teams

Genetic data is now central to how drugs are discovered, developed, and brought to patients. For teams designing precision medicine programs, understanding wher...
Continue reading

Precision medicine needs trial diversity to reduce bias

Precision medicine marks a shift from the one-size-fits-all approach to healthcare to tailored treatments and interventions that account for an individual's uni...
Continue reading

Multiple Sclerosis (MS) insights report: Impact, Treatment, Genetics, and Community

Our latest insights report explores multiple sclerosis (MS), providing details on the essential aspects of MS, from its impact on the central nervous system to ...
Continue reading

Webinar recap: Does the age of onset in SOD1 ALS affect the speed of progression?

Mutations in the SOD1 gene were the first identified genetic cause of ALS, discovered in 1993. Yet SOD1-ALS accounts for only approximately 2% of all ALS cases,...
Continue reading

Reflections from EASL: Genetic insights, potential treatments, and nomenclature transformations in liver disease

Last week, our team had the privilege of attending the European Association for the Study of the Liver (EASL) conference, where groundbreaking advancements in l...
Continue reading

Podcast recap: Lessons from the world's largest genomic datasets

In this episode of "The Genetics Podcast," host Patrick Short interviews Daniel McArthur, Director of the Centre for Population Genomics at the Garvan Institute...
Continue reading